Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

The drug appears effective against both “relapsing” and “primary progressive” forms of the disease, though some analysts ...

Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 readouts ...

If your Microsoft Account Recovery Form is rejected and you cannot recover your account, use the suggestions provided in this article.

Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster ...

Tech company says its ability to 'accumulate' AI chips in the UAE opens the path to invest billions in data centres there ...

Zydus receives US FDA final approval for diroximel fumarate delayed-release capsules, 231 mg: Our Bureau, Mumbai Thursday, November 13, 2025, 16:15 Hrs [IST] Zydus Lifesciences Li ...

AT&T reached a settlement after some customers' data was stolen. Who can get a check? How much could you be paid? When will ...

Genentech, a member of the Roche Group, has announced positive results from the first of two phase 3 trials investigating ...

The Government is to establish a new agency to oversee the delivery of Dublin’s MetroLink. Transport minister Darragh O’Brien ...

ROC Mumbai imposes penalty on Hexaware Technologies and officers for late filing of Form MR-2 for appointment of non-resident ...

Microsoft (NASDAQ:MSFT) said it will supply more than 60,000 advanced Nvidia (NVDA) artificial intelligence chips to the ...